Related Experiment Video
Updated: Jun 7, 2025

Author Spotlight: Achieving High-Purity In Vitro Differentiation of Th17 Cells Using Cytokine Concentration Modulation
Published on: October 25, 2024
Pseudokinase STK40 promotes TH1 and TH17 cell differentiation by targeting FOXO transcription factors
Yuexiao Tao1, Zhenyan Jiang1, Huizi Wang1
1Center for Immune-Related Diseases at Shanghai Institute of Immunology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine; Hongqiao International Institute of Medicine, Shanghai Tongren Hospital, Shanghai Jiao Tong University School of Medicine; Key Laboratory of Cell Differentiation and Apoptosis of the Chinese Ministry of Education, Shanghai Jiao Tong University School of Medicine; and Shanghai Institute of Immunology, Department of Immunology and Microbiology, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Insights
Pseudokinase STK40 promotes T helper 1/17 cell differentiation in autoimmune diseases by degrading FOXO1/4. Inhibiting STK40 may offer new treatments for inflammatory and autoimmune conditions.
Area of Science:
- Immunology
- Molecular Biology
- Cell Biology
Background:
- Dysregulated CD4+ T helper cell differentiation drives inflammatory and autoimmune diseases.
- Mechanisms controlling T helper cell transcription factor stability are not fully understood.
Purpose of the Study:
- To investigate the role of pseudokinase STK40 in T helper 1 (TH1) and T helper 17 (TH17) cell differentiation.
- To elucidate the molecular mechanisms by which STK40 regulates T helper cell differentiation under pathological conditions.
Main Methods:
- T cell-specific STK40 deletion in mice.
- Assessment of experimental autoimmune encephalomyelitis and colitis models.
- Analysis of TH1/TH17 cell differentiation.
- Investigation of STK40's interaction with FOXO1/4 and COP1 via ubiquitination assays.
Main Results:
- STK40 is dispensable for immune homeostasis in resting mice but crucial for TH1/TH17 differentiation in disease.
- Mice lacking T cell STK40 showed reduced experimental autoimmune encephalomyelitis and colitis severity.
- STK40 promotes TH1/TH17 differentiation by mediating K48-linked polyubiquitination and degradation of FOXO1/4 via COP1.
- Inhibition of FOXO1/4 rescued TH1/TH17 differentiation in STK40-deficient cells.
Conclusions:
- STK40 plays a critical role in pathological TH1 and TH17 cell differentiation.
- STK40 acts by promoting FOXO1/4 degradation, linking it to autoimmune disease progression.
- STK40 represents a potential therapeutic target for autoimmune diseases.
Abstract:
Inappropriate CD4+ T helper (TH) cell differentiation leads to progression of inflammatory and autoimmune diseases, yet the regulatory mechanisms governing stability and activity of transcription factors controlling TH cell differentiation remain elusive. Here, we describe how pseudokinase serine threonine kinase 40 (STK40) facilitates TH1/TH17 differentiation under pathological conditions. STK40 in T cells is dispensable for immune homeostasis in resting mice. However, mice with T cell-specific deletion of STK40 exhibit attenuated symptoms of experimental autoimmune encephalomyelitis and colitis, accompanied by diminished TH1 and TH17 cell differentiation. Mechanistically, STK40 facilitates K48-linked polyubiquitination and proteasomal degradation of FOXO1/4 through promoting their interaction with E3 ligase COP1. Inhibition of FOXO4 or FOXO1, respectively, restores differentiation potential of STK40-deficient TH1/TH17 cells. Together, our data suggest a crucial role of STK40 in TH1 and TH17 cell differentiation, thereby enabling better understanding of the molecular regulatory network of CD4+ T cell differentiation and providing effective targets for the treatment of autoimmune diseases.
Related Concept Videos
The JAK-STAT Signaling Pathway
PI3K/mTOR/AKT Signaling Pathway
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
TGF - β Signaling Pathway

